Results 131 to 140 of about 6,202 (185)

Glycoprotein VI inhibitors: glenzocimab and EMA601 two inhibitory Fabs. [PDF]

Eur Heart J
Mangin PH, Jandrot-Perrus M.
europepmc   +1 more source

Oroxylin A reverses SHP-2 oxidative inactivation in GPVI signaling to suppress platelet activation and thrombus formation [PDF]

Yufei Chen, Yuan Lin, Jin Tae Hong, Jiaorui Wang, B Li, Zixian Liu, Yongbo Ma, Sun Xiao-lan, Shufang Wang, Mingjie Li, Meiling Wu, Deyu Fu, Jian Li, Mingzhu Wang, Liang Hu   +14 more
openalex   +1 more source

Identification of a major GpVI-binding locus in human type III collagen [PDF]

, 2008
Gavin E. Jarvis, Nicolas Raynal, Jonathan P. Langford, David J. Onley, A F Andrews, Peter A. Smethurst, Richard W. Farndale   +6 more
openalex   +1 more source

Innovations in Platelet Cryopreservation: Evaluation of DMSO-Free Controlled-Rate Freezing and the Role of a Deep Eutectic Solvent as an Additional Cryoprotective Agent. [PDF]

Int J Mol Sci
Befekadu R, Bosnjak N, Uhlin M, Wikman A, Sandgren P.   +4 more
europepmc   +1 more source

GPVI-dependent functional competence of buffy coat platelet concentrates (PCs) versus PRP-derived PCs: insights into the effects of biomechanical forces during platelet preparation. [PDF]

Ann Hematol
Hosseini E, Beshkar P, Heydari F, Ghasemzadeh M.   +3 more
europepmc   +1 more source

GPVI inhibitor as antitumor gateway drug [PDF]

, 2019
Lawrence E. Goldfinger
openalex   +1 more source

Contrasting Effects of Platelet GPVI Deletion Versus Syk Inhibition on Mouse Jugular Vein Puncture Wound Structure. [PDF]

Int J Mol Sci
Pokrovskaya ID, Ball KK, Webb MW, Joshi S, Rhee SW, Ware J, Storrie B.   +6 more
europepmc   +1 more source

Correction: Thymidine phosphorylase in nucleotide metabolism: physiological functions and its implications in tumorigenesis and anti-cancer therapy. [PDF]

Front Immunol
Huang B, Yuan Q, Sun J, Wang C, Yang D.
europepmc   +1 more source

Differentially regulated GPVI ectodomain shedding by multiple platelet–expressed proteinases [PDF]

, 2010
Markus Bender, Sebastian Hofmann, David Stegner, Athena Chalaris, Michael R. Bösl, Attila Braun, Jürgen Scheller, Stefan Rose‐John, Bernhard Nieswandt   +8 more
openalex   +1 more source

NADPH oxidase 2 inhibitor GSK2795039 exerts antiplatelet and antithrombotic activity. [PDF]

Sci Rep
Oh EB, Kong YJ, Kim T, Jang J, Yu H, Park JW, Kim S, Kim T, Sohn J, Chang TS.   +9 more
europepmc   +1 more source